Eric H. Schoenstein - Jensen Investment Management Portfolio Performance Analysis (Q1 2026)

Investment performance metrics based on historical 13F filings data.

Data Coverage: June 2013 to March 2026 • Initial Portfolio Value: $0.01B

Performance calculated from first filing in our database. This may not represent the investor's entire career.

Portfolio Growth (Since First Filing)

+5.05B

+9,999%+

Winning Positions

+68.32%

138 wins / 202 positions

Average Gain (Winners)

$32.34M

+9,999%+ avg per position

Active Positions

82

56 losing positions

Portfolio Value Over Time

Current: $5.1B
Change: +$5.1B (99604.02%)
$13.6B $6.8B $5.0M
Jun 2013 Dec 2019 Mar 2026

Total Positions Tracked

202

All holdings over time

Win/Loss Ratio

2.46

138 gains / 56 losses

Active vs. Exited

82 / 120

Current positions / Exited

Position Performance

138 Gains / 56 Losses

Performance calculated from first appearance in 13F filings. Initial values represent position value when first tracked, not actual purchase prices.

Symbol Company Sector Entry Status Initial Value Current Value Gain/Loss Return %
MSFT Microsoft Corporation Technology Jun 2013 ACTIVE $234.24K $433.47M $433.24M +9,999%+
GOOGL Alphabet Inc. Communication Services Sep 2016 ACTIVE $134.94K $416.68M $416.55M +9,999%+
AAPL Apple Inc. Technology Jun 2015 ACTIVE $316.00 $405.03M $405.03M +9,999%+
PFE Pfizer, Inc. Healthcare Jun 2013 EXITED $498.00 $339.02M $339.02M +9,999%+
MA Mastercard Incorporated Financial Services Sep 2015 ACTIVE $111.75K $245.30M $245.19M +9,999%+
SYK Stryker Corporation Healthcare Jun 2013 ACTIVE $6.73K $228.82M $228.81M +9,999%+
LLY Eli Lilly and Company Healthcare Sep 2013 ACTIVE $423.00 $212.16M $212.16M +9,999%+
SHW Sherwin-Williams Company (The) Basic Materials Mar 2015 ACTIVE $555.00 $200.76M $200.76M +9,999%+
MMC Marsh & McLennan Companies, Inc Financial Services Jun 2021 ACTIVE $166.73K $199.68M $199.51M +9,999%+
ABT Abbott Laboratories Healthcare Jun 2013 ACTIVE $194.67K $152.57M $152.38M +9,999%+
Page 1 of 21

Important Note: Data Limitations

These metrics are based on 13F filing data which has significant limitations:

  • Quarterly Snapshots Only: 13F filings show positions at quarter-end, not actual transaction prices
  • No Transaction Prices: We cannot determine actual buy/sell prices, only end-of-quarter values
  • Performance Estimates: Gains/losses are calculated from first appearance to last update using quarterly values
  • Missing Data: Intra-quarter trades, dividends, corporate actions, and exact timing are not captured
  • Educational Only: These metrics are estimates for understanding general investment patterns, not actual realized returns

Use these metrics for informational and educational purposes only. They represent broad trends, not precise investment performance.